Skip to main content

Table 2 Foetal and placental parameters in Walker tumour-bearing rats and ascitic fluid-injected rats fed either a control or leucine-rich diet

From: Dietary leucine supplementation minimises tumour-induced damage in placental tissues of pregnant, tumour-bearing rats

 

C

W

A

L

LW

LA

Interaction effectb

Tumour effectb

Diet effectb

Foetal resorption per dam

0.900±0.314

3.300±0.538*

2.500±0.562*

0.889±0.309

1.600±0.499

1.700±0.473

P = 0.0321

P = 0.0043

n.s.

Foetal weight (g)

3.92 ± 0.07

2.73 ± 0.20*

2.61 ± 0.05*

3.65 ± 0.06

2.85 ± 0.08*

2.96 ± 0.09*

n.s.

P < 0.0001

n.s.

Placenta weight (g)

0.48 ± 0.01

0.53 ± 0.02

0.42 ± 0.02

0.52 ± 0.03

0.52 ± 0.01

0.50 ± 0.02

n.s.

n.s.

n.s.

Placental protein content (μg/mg)

7.38 ± 0.48

3.81 ± 0.29*

4.70 ± 0.34*

7.14 ± 0.28

6.87 ± 0.56

6.37 ± 0.67

P = 0.0043

P = 0.0002

n.s.

Placental DNA (μg/mg)

0.46 ± 0.02

0.38 ± 0.02*

0.38 ± 0.02*

0.46 ± 0.03

0.49 ± 0.02

0.43 ± 0.04

n.s.

P = 0.0052

n.s.

Placental protein/DNA ratioa

16.8 ± 1.2

11.5 ± 0.9*

14.2 ± 1.5

17.3 ± 1.1

15.4 ± 1.5

17.3 ± 2.5

P = 0.0212

P = 0.0311

n.s.

  1. Caption: Control (C), Leucine (L), Walker tumour-bearing rats (W), tumour-bearing rats subjected to a leucine-rich diet (LW), rats inoculated with ascitic fluid (A), and rats inoculated with ascitic fluid and subjected to a leucine-rich (LA). The results are expressed as the mean and standard deviation. *P < 0.05 compared with the control group. aPlacental protein/DNA ratio was used as an index of cell size. b Significant difference accounted by tumour, diet or interaction effect, analysed by two-way ANOVA with Bonferroni testing, n.s. = non-significant